Cite
Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency
MLA
Goodship, J., et al. “Use of X Chromosome Inactivation Analysis to Establish Carrier Status for X-Linked Severe Combined Immunodeficiency.” The Lancet, vol. v1, no. n8588, Apr. 1988, p. 729. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.6708499&authtype=sso&custid=ns315887.
APA
Goodship, J., Lau, Y. L., Malcolm, S., Pembrey, M. E., & Levinsky, R. J. (1988). Use of X chromosome inactivation analysis to establish carrier status for X-linked severe combined immunodeficiency. The Lancet, v1(n8588), 729.
Chicago
Goodship, J., Y.L. Lau, S. Malcolm, M.E. Pembrey, and R.J. Levinsky. 1988. “Use of X Chromosome Inactivation Analysis to Establish Carrier Status for X-Linked Severe Combined Immunodeficiency.” The Lancet v1 (n8588): 729. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.6708499&authtype=sso&custid=ns315887.